SEC 13F Intelligence

Checkpoint Capital L.P. / PHAT

Checkpoint Capital L.P.’s Phathom Pharmaceuticals Inc Position

Does Checkpoint Capital L.P. own Phathom Pharmaceuticals Inc (PHAT)? Not currently — the last reported position was 2.27M shares worth $18M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$18M
Q4 2024
Shares
2.27M
% of Portfolio
+9.40%
Quarters Held
5
position exited

Position History PHAT

Reported value by quarter
Q4 ’23: $3MQ4 ’23Q1 ’24: $5MQ1 ’24Q2 ’24: $9MQ2 ’24Q3 ’24: $27MQ3 ’24Q4 ’24: $18MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20242.27M$18M+9.40%
Q3 20241.50M$27M+13.49%
Q2 2024875.0K$9M+5.43%
Q1 2024445.2K$5M+3.16%
Q4 2023359.4K$3M+1.99%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Checkpoint Capital L.P.’s full portfolio or all institutional holders of PHAT.